Literature DB >> 12684733

Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats.

Rajeev I Desai1, David J Barber, Philip Terry.   

Abstract

RATIONALE: Previous work has demonstrated asymmetrical cross-generalization between the discriminative stimulus effects of nicotine and cocaine: nicotine fully substitutes for cocaine, whereas cocaine only partially substitutes for nicotine. The factors responsible for the similarities and differences between the two drugs remain unclear.
OBJECTIVE: The study tested the involvement of dopaminergic and/or cholinergic mechanisms in the discriminative stimulus effects of nicotine and cocaine.
METHODS: One set of rats was trained to discriminate cocaine (8.9 mg/kg) from saline, and two other sets of rats were trained to discriminate nicotine (0.1 mg/kg) from saline.
RESULTS: In cocaine-trained rats, among the cholinergic agonists studied only nicotine (0.01-0.56 mg/kg) produced full, dose-related substitution; nornicotine (1-5.6 mg/kg) substituted only partially, and lobeline (2.71-15.34 mg/kg) and pilocarpine (0.26-2.55 mg/kg) failed to engender any cocaine-appropriate responding. The nicotinic antagonist mecamylamine (1-5.6 mg/kg) failed to block cocaine's discriminative stimulus effects. The dopamine antagonist cis-flupentixol (0.48 mg/kg) blocked the substitution of nicotine for cocaine. In nicotine-trained rats, the dopamine uptake blockers cocaine, bupropion and nomifensine (0.2-26.1 mg/kg) each substituted only partially for nicotine, and cis-flupentixol (0.48-0.86 mg/kg) antagonized the discriminative stimulus effects of nicotine.
CONCLUSIONS: Nicotine fully substitutes for cocaine because of its effects on dopamine transmission, and not because the discriminative stimulus effects of cocaine incorporate a cholinergic component. Substitution of nicotine for cocaine may depend more on nicotine-induced dopamine release than does the nicotine-trained discriminative stimulus; there may be differential dopaminergic involvement after acute and repeated treatment with nicotine or cocaine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684733     DOI: 10.1007/s00213-003-1426-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  56 in total

1.  Interaction of nicotine with dopaminergic mechanisms assessed through drug discrimination and rotational behaviour in rats.

Authors:  C Reavill; I P Stolerman
Journal:  J Psychopharmacol       Date:  1987-01       Impact factor: 4.153

2.  Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine.

Authors:  J L Katz; S Izenwasser; R H Kline; A C Allen; A H Newman
Journal:  J Pharmacol Exp Ther       Date:  1999-01       Impact factor: 4.030

3.  Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers.

Authors:  H E Jones; B E Garrett; R R Griffiths
Journal:  J Pharmacol Exp Ther       Date:  1999-01       Impact factor: 4.030

4.  A novel nicotinic-cholinergic role in behavioral sensitization to amphetamine-induced stereotypy in mice.

Authors:  R Karler; L D Calder; J B Bedingfield
Journal:  Brain Res       Date:  1996-07-01       Impact factor: 3.252

5.  Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.

Authors:  F E Pontieri; G Tanda; F Orzi; G Di Chiara
Journal:  Nature       Date:  1996-07-18       Impact factor: 49.962

6.  Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline.

Authors:  C Reavill; B Walther; I P Stolerman; B Testa
Journal:  Neuropharmacology       Date:  1990-07       Impact factor: 5.250

7.  Asymmetric generalization between the discriminative stimulus effects of nicotine and cocaine.

Authors:  R I Desai; D J Barber; P Terry
Journal:  Behav Pharmacol       Date:  1999-11       Impact factor: 2.293

8.  Nicotine and heroin augment cocaine-induced dopamine overflow in nucleus accumbens.

Authors:  G Zernig; I A O'Laughlin; H C Fibiger
Journal:  Eur J Pharmacol       Date:  1997-10-15       Impact factor: 4.432

9.  Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain.

Authors:  D J Anderson; S P Arneric
Journal:  Eur J Pharmacol       Date:  1994-03-03       Impact factor: 4.432

10.  Role of training dose in discrimination of nicotine and related compounds by rats.

Authors:  I P Stolerman; H S Garcha; J A Pratt; R Kumar
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more
  33 in total

Review 1.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

2.  Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats.

Authors:  M Jerry Wright; Robert E Vann; Thomas F Gamage; M Imad Damaj; Jenny L Wiley
Journal:  Pharmacol Biochem Behav       Date:  2006-11-16       Impact factor: 3.533

3.  Nicotine as a typical drug of abuse in experimental animals and humans.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2005-10-05       Impact factor: 4.530

4.  Discriminative and reinforcing stimulus effects of nicotine, cocaine, and cocaine + nicotine combinations in rhesus monkeys.

Authors:  Nancy K Mello; Jennifer L Newman
Journal:  Exp Clin Psychopharmacol       Date:  2011-06       Impact factor: 3.157

5.  Nicotinic effects of tobacco smoke constituents in nonhuman primates.

Authors:  Rajeev I Desai; Michelle R Doyle; Sarah L Withey; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2016-02-19       Impact factor: 4.530

Review 6.  Interactions between nicotine and drugs of abuse: a review of preclinical findings.

Authors:  Stephen J Kohut
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-02       Impact factor: 3.829

7.  Effects of the Nanoparticle-Based Vaccine, SEL-068, on Nicotine Discrimination in Squirrel Monkeys.

Authors:  Rajeev I Desai; Jack Bergman
Journal:  Neuropsychopharmacology       Date:  2015-03-06       Impact factor: 7.853

8.  Pavlovian drug discrimination with bupropion as a feature positive occasion setter: substitution by methamphetamine and nicotine, but not cocaine.

Authors:  Jamie L Wilkinson; Chia Li; Rick A Bevins
Journal:  Addict Biol       Date:  2008-12-12       Impact factor: 4.280

Review 9.  Effects of nicotine in experimental animals and humans: an update on addictive properties.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Handb Exp Pharmacol       Date:  2009

10.  Effects of the nicotinic acetylcholine receptor antagonist mecamylamine on the discriminative stimulus effects of cocaine in male rhesus monkeys.

Authors:  Matthew L Banks
Journal:  Exp Clin Psychopharmacol       Date:  2014-02-17       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.